SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants

Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19

(2021) Perrine Janiaud et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

(2021) Ester C Sabino et al.   LANCET

SARS Coronavirus-2 Microneutralisation and Commercial Serological Assays Correlated Closely for Some but Not All Enzyme Immunoassays

(2021) Gregory J. Walker et al.   Viruses-Basel

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

(2020) Markus Hoffmann et al.   CELL

Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho

(2020) Andrew Bryan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients

(2020) Christoph Kreer et al.   CELL

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

(2020) Qianqian Li et al.   CELL

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

(2020) Bette Korber et al.   CELL

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

(2020) Marina Pollán et al.   LANCET

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

(2020) Davide F. Robbiani et al.   NATURE

Revealing COVID-19 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling

(2020) Rebecca J. Rockett et al.   NATURE MEDICINE

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

(2020) F. Javier Ibarrondo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model

(2020) Thomas F. Rogers et al.   SCIENCE

Clinical efficacy of convalescent plasma for treatment of COVID-19 infections: Results of a multicenter clinical study

(2020) Hassan Abolghasemi et al.   TRANSFUSION AND APHERESIS SCIENCE

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

(2020) Leonid Yurkovetskiy et al.   CELL

Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population

(2020) Sabra L. Klein et al.   JOURNAL OF CLINICAL INVESTIGATION

Humoral Immune Response to SARS-CoV-2 in Iceland

(2020) Daniel F. Gudbjartsson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity

(2020) Ellen Shrock et al.   SCIENCE

Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination

(2019) Fiona Tea et al.   Acta Neuropathologica Communications

Nextstrain: real-time tracking of pathogen evolution

(2018) James Hadfield et al.   BIOINFORMATICS

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation

(2017) Tongqing Zhou et al.   Cell Reports

Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design

(2016) Dennis R. Burton et al.   Annual Review of Immunology

A clinical approach to diagnosis of autoimmune encephalitis

(2016) Francesc Graus et al.   LANCET NEUROLOGY

Influenza Vaccines: Challenges and Solutions

(2015) Katherine Houser et al.   Cell Host & Microbe

Mobilization of HIV Spread by Diaphanous 2 Dependent Filopodia in Infected Dendritic Cells

(2012) Anupriya Aggarwal et al.   PLoS Pathogens